Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

COVID-19 can cause temporary hair loss.

Long-COVID has diverse, long-term health impacts, especially in young people.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Low testosterone levels may lead to more severe COVID-19 outcomes.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

Vitamin D is crucial for skin health and managing skin diseases.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

A man got heart and swelling issues from a hair loss medication, so doctors advise careful use, especially in people with past health problems.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.